Why is Abbott Laboratories stock down today?

Traders Union
All News
Financial News
Abbott Laboratories slides 2.16% today

Highlights

Abbott Laboratories continues to trade well below key moving averages, underscoring persistent selling pressure across all timeframes.
Momentum and oscillator signals are unanimously bearish, with technical indicators indicating a deeply oversold and downward-trending state.
Five-day price range is expected between $79.31 and $84.59, with upside scenarios deemed unlikely absent a breakout above $84.59.

Anton Kharitonov, expert at Traders Union, observes strong technical weakness in Abbott Laboratories. He notes that the shares are trading well below all key moving averages, highlighting broad-based selling pressure. The momentum profile is firmly bearish, with no bullish triggers present in major indicators. Absence of positive news compounds the technical risks, leaving the stock vulnerable to continued downside. "This setup signals heightened caution — there is no technical or fundamental support visible in the near term," warns Kharitonov.

Viktoras Karapetjanc, expert at Traders Union, acknowledges recent declines but keeps a forward-looking stance. He points to the stock’s ability to maintain a support band, suggesting that volatility could offer new opportunities for patient investors. While major technical signals are negative, Karapetjanc believes the longer-term growth structure is not fully broken and upside may emerge if stability returns. He sees the lack of news as a chance for fundamentals to reassert their role. "I remain optimistic that the current range creates setups for eventual recovery once short-term pressures subside," Karapetjanc states.

Persistent bearish momentum as oscillators deepen oversold conditions

Abbott Laboratories remains well below its 20-, 50-, and 200-day moving averages ($92.51, $101.25, and $119.61 respectively), reflecting persistent short-, medium-, and long-term selling pressure. The nearest resistance is defined by the Ichimoku Kijun level at $93.96, with no immediate dynamic support in sight.

Momentum indicators present a strongly bearish profile, with both the Moving Average Convergence Divergence (MACD) and Average Directional Index (ADX) showing persistent downside pressure. The Relative Strength Index (RSI), Stochastic RSI, and Commodity Channel Index (CCI) are all deep in oversold territory, indicating a stretched short-term state. Bull/Bear Power (BBP) shows sellers firmly dominating intraday momentum, further confirming the oversold conditions. The Awesome Oscillator also aligns with the prevailing downtrend. The stock is trading at $82.48, down $1.82 or 2.16%, having opened with an upside gap of approximately $0.35. Price action is near the session’s low, intraday volatility stands at 2.55%, and the tone suggests sustained pressure after the open. Intraday performance reinforces the strong bearish momentum without major divergence among oscillators and momentum signals.

Earlier, analysts noted that Abbott Laboratories faced persistent downside pressure with a broadly bearish technical outlook across key indicators. The current analysis reinforces this negative trend, underscoring the importance of monitoring whether the stock can hold above the $79.31 level, as a breakdown below this support could signal renewed downside momentum.

Source of Data: ABT Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.